TLRY Tilray

Tilray Brands, Inc. to Announce Second Quarter Fiscal Year 2025 Financial Results on January 9, 2025

Tilray Brands, Inc. to Announce Second Quarter Fiscal Year 2025 Financial Results on January 9, 2025

NEW YORK and LEAMINGTON, Ontario, Dec. 19, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global lifestyle and consumer packaged goods company, today announced that the Company will release its financial results for the second quarter ended November 30, 2024 before the financial market opens on January 9, 2025.

Live Conference Call and Audio Webcast

Tilray will host a live conference call, which will be webcast, to discuss these results at 8:30 a.m. Eastern Time. The webcast can be accessed on the Investors section of Tilray's website at .

About Tilray Brands

Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy, wellness and create memorable experiences. Tilray’s unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

For more information on how we are elevating lives through moments of connection, visit Tilray.com and follow @Tilray on all social platforms.

Media Contact:

Investor Contact:



EN
19/12/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Tilray

 PRESS RELEASE

Breckenridge Brewery Launches New Seasonal Brew: Spring Forward Grapef...

Breckenridge Brewery Launches New Seasonal Brew: Spring Forward Grapefruit IPA Bursting with Bright Citrus Flavor, the Limited-Release IPA Hits Shelves This Month BRECKENRIDGE, Colo., Jan. 14, 2025 (GLOBE NEWSWIRE) -- , a subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is thrilled to introduce its new seasonal beer release, . This vibrant brew masterfully balances bold grapefruit and refreshing zesty citrus flavors with just the right level of hop-driven bitterness. Spring Forward Grapefruit IPA bursts with a crisp, clean finish that shines in the popular IPA category...

 PRESS RELEASE

Tilray Brands Reports Q2 2025 Financial Results

Tilray Brands Reports Q2 2025 Financial Results Gross Profit Increased by 29% Year-Over-Year, Reaching $61 Million in Q2 with Growth Across All Four Business Segments Achieved 9% Year-Over-Year Growth, Generating Record Q2 Net Revenue of $211 Million, 10% in Constant Currency Beverage Revenue Increase by 36%, International Cannabis by 25%, Wellness Segment by 13% Announces Project 420: A $25 Million Synergy Plan for Tilray Beverage Business Tilray Reaffirms Fiscal Year 2025 Guidance Conference Call to be Held at 8:30 a.m. ET Today NEW YORK and LEAMINGTON, Ontario, Jan. 10, 2025 (GLO...

 PRESS RELEASE

Tilray Medical Wins Tender to Supply Luxembourg with Medical Cannabis

Tilray Medical Wins Tender to Supply Luxembourg with Medical Cannabis NEUMÜNSTER, Germany, Jan. 06, 2025 (GLOBE NEWSWIRE) -- , a division of Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), proudly announces that its German subsidiary, Tilray Deutschland GmbH, has secured a tender to supply Luxembourg with its high-quality cannabis flower. The granting of this tender by the Ministry of Health and Social Security for the Grand Duchy of Luxembourg highlights the trust placed in Tilray Medical to deliver high-quality medical cannabis on a consistent basis across the global medical cannabis ind...

 PRESS RELEASE

Tilray Medical remporte un appel d’offres pour l’approvisionnement du ...

Tilray Medical remporte un appel d’offres pour l’approvisionnement du Luxembourg en cannabis thérapeutique NEUMÜNSTER, Allemagne, 06 janv. 2025 (GLOBE NEWSWIRE) -- , une division de Tilray Brands, Inc. (Nasdaq : TLRY ; TSX : TLRY), est fière d’annoncer que sa filiale allemande, Tilray Deutschland GmbH, a remporté un appel d’offres pour l’approvisionnement du Luxembourg en fleurs de cannabis de haute qualité. Avec l’octroi de cet appel d’offres, le Ministère de la Santé et de la Sécurité sociale du Grand-Duché de Luxembourg souligne la confiance qu’il accorde à Tilray Medical pour la fourn...

 PRESS RELEASE

Tilray Medical gewinnt Ausschreibung zur Belieferung Luxemburgs mit me...

Tilray Medical gewinnt Ausschreibung zur Belieferung Luxemburgs mit medizinischem Cannabis NEUMÜNSTER, Deutschland, Jan. 06, 2025 (GLOBE NEWSWIRE) -- , ein Geschäftsbereich von Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), freut sich bekanntgeben zu können, dass seine deutsche Tochtergesellschaft, die Tilray Deutschland GmbH, eine Ausschreibung für die Belieferung Luxemburgs mit seinen hochwertigen Cannabisblüten gewonnen hat. Die Erteilung dieses Auftrags durch das Ministerium für Gesundheit und soziale Sicherheit des Großherzogtums Luxemburg unterstreicht das Vertrauen, das Tilray Medi...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch